Quantinno Capital Management LP Intercept Pharmaceuticals, Inc. Transaction History

Quantinno Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $246,423 - $336,885	-6,304 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $178,067 - $350,948	-3,813 Reduced 37.69%	6,304 $302,000
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $261,283 - $641,346	5,404 Added 114.66%	10,117 $637,000
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $270,337 - $584,883	4,713 New	4,713 $584,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Quantinno Capital Management LP with notifications on news.